Research ExplorerPublicationsThe Increasing Role of Rhythm Control in Patients With Atria...

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review

Standard

The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. / Camm, A John; Naccarelli, Gerald V; Mittal, Suneet; Crijns, Harry J G M; Hohnloser, Stefan H; Ma, Chang-Sheng; Natale, Andrea; Turakhia, Mintu P; Kirchhof, Paulus.

In: J AM COLL CARDIOL, Vol. 79, No. 19, 17.05.2022, p. 1932-1948.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Camm, AJ, Naccarelli, GV, Mittal, S, Crijns, HJGM, Hohnloser, SH, Ma, C-S, Natale, A, Turakhia, MP & Kirchhof, P 2022, 'The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review', J AM COLL CARDIOL, vol. 79, no. 19, pp. 1932-1948. https://doi.org/10.1016/j.jacc.2022.03.337

APA

Camm, A. J., Naccarelli, G. V., Mittal, S., Crijns, H. J. G. M., Hohnloser, S. H., Ma, C-S., Natale, A., Turakhia, M. P., & Kirchhof, P. (2022). The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J AM COLL CARDIOL, 79(19), 1932-1948. https://doi.org/10.1016/j.jacc.2022.03.337

Vancouver

Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser SH, Ma C-S et al. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J AM COLL CARDIOL. 2022 May 17;79(19):1932-1948. https://doi.org/10.1016/j.jacc.2022.03.337

Bibtex

@article{2ce9e196fa354552b6db95844fc7681a,
title = "The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review",
abstract = "The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Although the management of AF historically focused on decreasing AF recurrence, it evolved over time in favor of rate control. Recently, more emphasis has been placed on reducing adverse cardiovascular outcomes using rhythm control, generally by using safe and effective rhythm-control therapies (typically antiarrhythmic drugs and/or AF ablation). Evidence increasingly supports early rhythm control in patients with AF that has not become long-standing, but current clinical practice and guidelines do not yet fully reflect this change. Early rhythm control may effectively reduce irreversible atrial remodeling and prevent AF-related deaths, heart failure, and strokes in high-risk patients. It has the potential to halt progression and potentially save patients from years of symptomatic AF; therefore, it should be offered more widely.",
keywords = "Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation/drug therapy, Atrial Remodeling, Catheter Ablation/adverse effects, Humans, Stroke/etiology, Treatment Outcome",
author = "Camm, {A John} and Naccarelli, {Gerald V} and Suneet Mittal and Crijns, {Harry J G M} and Hohnloser, {Stefan H} and Chang-Sheng Ma and Andrea Natale and Turakhia, {Mintu P} and Paulus Kirchhof",
note = "Copyright {\textcopyright} 2022 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2022",
month = may,
day = "17",
doi = "10.1016/j.jacc.2022.03.337",
language = "English",
volume = "79",
pages = "1932--1948",
journal = "J AM COLL CARDIOL",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "19",

}

RIS

TY - JOUR

T1 - The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review

AU - Camm, A John

AU - Naccarelli, Gerald V

AU - Mittal, Suneet

AU - Crijns, Harry J G M

AU - Hohnloser, Stefan H

AU - Ma, Chang-Sheng

AU - Natale, Andrea

AU - Turakhia, Mintu P

AU - Kirchhof, Paulus

N1 - Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2022/5/17

Y1 - 2022/5/17

N2 - The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Although the management of AF historically focused on decreasing AF recurrence, it evolved over time in favor of rate control. Recently, more emphasis has been placed on reducing adverse cardiovascular outcomes using rhythm control, generally by using safe and effective rhythm-control therapies (typically antiarrhythmic drugs and/or AF ablation). Evidence increasingly supports early rhythm control in patients with AF that has not become long-standing, but current clinical practice and guidelines do not yet fully reflect this change. Early rhythm control may effectively reduce irreversible atrial remodeling and prevent AF-related deaths, heart failure, and strokes in high-risk patients. It has the potential to halt progression and potentially save patients from years of symptomatic AF; therefore, it should be offered more widely.

AB - The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Although the management of AF historically focused on decreasing AF recurrence, it evolved over time in favor of rate control. Recently, more emphasis has been placed on reducing adverse cardiovascular outcomes using rhythm control, generally by using safe and effective rhythm-control therapies (typically antiarrhythmic drugs and/or AF ablation). Evidence increasingly supports early rhythm control in patients with AF that has not become long-standing, but current clinical practice and guidelines do not yet fully reflect this change. Early rhythm control may effectively reduce irreversible atrial remodeling and prevent AF-related deaths, heart failure, and strokes in high-risk patients. It has the potential to halt progression and potentially save patients from years of symptomatic AF; therefore, it should be offered more widely.

KW - Anti-Arrhythmia Agents/therapeutic use

KW - Atrial Fibrillation/drug therapy

KW - Atrial Remodeling

KW - Catheter Ablation/adverse effects

KW - Humans

KW - Stroke/etiology

KW - Treatment Outcome

U2 - 10.1016/j.jacc.2022.03.337

DO - 10.1016/j.jacc.2022.03.337

M3 - SCORING: Review article

C2 - 35550691

VL - 79

SP - 1932

EP - 1948

JO - J AM COLL CARDIOL

JF - J AM COLL CARDIOL

SN - 0735-1097

IS - 19

ER -